LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

HomeStock ListAbbott Laboratories

Abbott Laboratories

Closed

Sector Healthcare

109.04 -2.19

Overview

Share price change

24h

Current

Min

108.47

Max

111.5

Key metrics

By Trading Economics

Income

158M

1.6B

Sales

98M

10B

P/E

Sector Avg

37.327

23.904

EPS

1.19

Dividend yield

1.871

Profit margin

15.565

Employees

114,000

EBITDA

132M

2.4B

Recommendations

By TipRanks

Rating Consensus

StrongBuy

12 Months Forecast

+14.14 upside

Dividends

By Dow Jones

Dividend Yield

Sector avg

1.87%

7.76%

Next earnings

17 Apr 2024

Next Dividend date

15 May 2024

Next Ex Dividend date

11 Jul 2024

Market Stats

By TradingEconomics

Market Cap

-1.2B

192B

Previous open

111.23

Previous close

109.04

News Sentiment

By Acuity

50%

50%

74 / 274 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Abbott Laboratories chart

Related News

24 Jan 2024, 13:04 UTC

Earnings

Abbott Labs Posts Higher 4Q Sales, Despite Soft Demand For Covid Tests

24 Jan 2024, 15:13 UTC

Earnings

Abbott Labs Shares Are Down Despite Solid Profit Increase -- WSJ

24 Jan 2024, 13:55 UTC

Top News
Earnings

Abbott Labs Skids On Light Earnings Guidance Despite Quarterly Sales Beat -- IBD

24 Jan 2024, 13:01 UTC

Earnings

Abbott Laboratories Stock Is Down. Earnings, Sales Aren't the Problem. -- Barrons.com

24 Jan 2024, 12:34 UTC

Earnings

Abbott Labs Sees FY24Organic Sales Growth, Excluding COVID-19 Testing-Related Sales, to Be in the Range of 8.0% to 10.0% >ABT

24 Jan 2024, 12:33 UTC

Earnings

Abbott Labs Sees FY24 Adj EPS $4.50-Adj EPS $4.70 >ABT

24 Jan 2024, 12:33 UTC

Earnings

Abbott Labs Sees FY24 EPS $3.20-EPS $3.40 >ABT

24 Jan 2024, 12:30 UTC

Earnings

Abbott Labs 4Q Organic Sales Growth Up 2.1% >ABT

24 Jan 2024, 12:30 UTC

Earnings

Abbott Labs 4Q EPS 91c >ABT

24 Jan 2024, 12:30 UTC

Earnings

Abbott Labs 4Q Sales $10.24B >ABT

24 Jan 2024, 12:30 UTC

Earnings

Abbott Labs 4Q Net $1.59B >ABT

24 Jan 2024, 12:30 UTC

Earnings

Abbott Labs Sees FY Adj EPS $4.50-Adj EPS $4.70 >ABT

24 Jan 2024, 12:30 UTC

Earnings

Abbott Labs 4Q Adj EPS $1.19 >ABT

24 Jan 2024, 12:30 UTC

Earnings

Abbott Labs Sees FY EPS $3.20-EPS $3.40 >ABT

24 Jan 2024, 09:39 UTC

Hot Stocks

Stocks to Watch Wednesday: Tesla, Netflix, IBM, Texas Instruments -- WSJ

19 Oct 2023, 15:56 UTC

Earnings

Abbott Earnings Show How Obesity Drug Worries Are Overblown -- Barrons.com

18 Oct 2023, 12:49 UTC

Earnings

Abbott Stock Is Rising. Earnings Beat and Guidance Was Strong. -- Barrons.com

18 Oct 2023, 12:02 UTC

Earnings

Abbott Labs 3Q Profit Flat as Sales Fall -- Earnings Review

18 Oct 2023, 11:31 UTC

Earnings

Abbott Labs Still Sees 2023 Organic Sales Ex-Covid-19 Testing Up Low-Double Digits >ABT

18 Oct 2023, 11:31 UTC

Earnings

Abbott Labs 3Q Organic Sales for Underlying Base Business Rose 13.8% >ABT

18 Oct 2023, 11:30 UTC

Earnings

Abbott Labs Raises Midpoint of Full-Year EPS Guidance Range >ABT

18 Oct 2023, 11:30 UTC

Earnings

Abbott Labs Sees FY Adj EPS $4.42-Adj EPS $4.46 >ABT

18 Oct 2023, 11:30 UTC

Earnings

Abbott Labs 3Q Net $1.44B >ABT

18 Oct 2023, 11:30 UTC

Earnings

Abbott Labs 3Q Sales $10.14B >ABT

18 Oct 2023, 11:30 UTC

Earnings

Abbott Labs 3Q Adj EPS $1.14 >ABT

18 Oct 2023, 11:30 UTC

Earnings

Abbott Labs Sees FY EPS $3.14-EPS $3.18 >ABT

18 Oct 2023, 11:30 UTC

Earnings

Abbott Labs 3Q EPS 82c >ABT

18 Oct 2023, 08:37 UTC

Top News

These Stocks Are Moving the Most Today: United, Morgan Stanley, ASML, J.B. Hunt, Tesla, Netflix, and More -- Barrons.com

22 Sept 2023, 12:48 UTC

Acquisitions, Mergers, TakeOvers

Abbott Completes Acquisition Of Bigfoot Biomedical >ABT

22 Sept 2023, 12:48 UTC

Acquisitions, Mergers, TakeOvers

Abbott Completes Acquisition Of Bigfoot Biomedical >ABT

Peer Comparison

Price change

Abbott Laboratories forecast

Price Target

By TipRanks

14.14% upside

12 Months Forecast

Average 127.21 USD  14.14%

High 141 USD

Low 107 USD

Based on 14 Wall Street analysts offering 12 month price targets for Abbott Laboratories - Dist in the last 3 months.

Rating Consensus

By TipRanks

StrongBuy

14 ratings

12

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

111.18 / 111.82 Support&Resistance

Short Team

Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

74 / 274 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.